Pharmaceutical Antimalarial Lumefantrine Powder Lumefantrine

• Customization: Available
• Powder: Yes
• Customized: Negotiable
• Model NO.: QS-Lumefantrine
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Product Name: Lumefantrine
• Name: Lumefantrine Powder
• Appearance: Yellow Powder
• Colour: Yellow
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• CAS: 82186-77-4
• Density: 1.252
• Mf: C30h32cl3no
• MW: 528.94018
• Melting Point: 129-131c
• Boiling Point: 642.5c
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Lumefantrine
• Origin: Xian
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical Antimalarial Lumefantrine Powder Lumefantrine

Product Description

Product Details

Product Name	Lumefantrine Powder
Appearance	Yellow Powder
Assay	99%
CAS	82186-77-4
MW	528.94018

Lumefantrine is a new mequindox drug created in our country. It has a significant killing effect on both sexually transmitted and non-sexually transmitted malaria and has a good preventive effect against vivax malaria.

Application&Function

Function
Lumefantrine (Benflumetol) is a new kinds of mefloquine drug.
Obvious Effect of killing vivax malaria, as well as in preventing.
It also can kill the Falciparum malaria phorozoon, but slow effect. It can reduce the gametophyte rate in blood, suppression the development of the gametophyte in mosquitoes. The cure rate of chloroquine-resistant and multidrug-resistant falciparum malaria is more than 95%. Animal experiments show that the toxicity of this product is very low, and no adverse reaction on the clinical.
Application
It is mainly used for the treatment of cerebral malaria (malarial malaria), especially for the treatment of cerebral malaria (palatal malaria) caused by chloroquine-resistant strains.

Specification